USPTO Patents Application 10701244

Application No. 10/701,244
Paper Dated: October 1 8, 2007
Attorney Docket No.: CV01679US (4686-050103)

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE

Applicants: Jay S. Fine et al.
Appl.No.: 10/701,244

Group Art Unit: 1617
Examiner: San Ming R. Hui

Filed:

November 4, 2003

Case No.: CV01679US

For:

Methods and Therapeutic Combinations
For the Treatment of Demyelination

Confirmation No.: 6101

SUPPLEMENTAL INFORMATION DISCLOSURE STATEMENT

MAIL STOP AMENDMENT
Commissioner for Patents
P.O. Box 1450
Alexandria, VA 22313-1450

Sir:

Applicants respectfully request that the following be considered and made of record, as well
as the documents listed on the accompanying PTO Form SB/08A.

(a) Pursuant to the duty of disclosure under 37 C.F.R. §1.56, it is requested that the
documents listed on the accompanying Form SB/08A be considered and made of record in the above-
identified patent application. Copy(ies) of these documents [X] are enclosed Q were filed in related
U.S. Application No(s) filed , respectively.

(b) No fee is believed to be due because:

□ This Information Disclosure Statement is being submitted concurrently with
the filing of the above-identified application; or

n This Information Disclosure Statement is being submitted within three (3)
months of the filing date of the above-identified application; or

O This Information Disclosure Statement is being submitted concurrently with a
Request for Continued Examination (RCE); or

□ This Information Disclosure Statement is being submitted prior to the mailing
of a first Office Action on the merits.

(c) [X] This Information Disclosure Statement is being submitted before the mailing
date of any final action, notice of allowance, or an action that otherwise
closes prosecution; and:

□ Each item of information contained in this Information Disclosure
Statement was first cited in a communication from a foreign patent
office in a counterpart foreign application not more than three months
prior to the filing of this Information Disclosure Statement; or

□ No item of information contained in this Information Disclosure
Statement was cited in a communication from a foreign patent office

KC1921.DOC

1

Application No. 10/701,244
Paper Dated: October 1 8, 2007
Attorney Docket No.: CV01679US (4686-050103)

in a counterpart foreign application, and, to the knowledge of the
undersigned after making reasonable inquiry, no item of information
contained in this Information Disclosure Statement was known to any
individual designated in § 1.56(c), more than three months prior to the
filing of this Information Disclosure Statement; or

□ The Commissioner is hereby authorized to charge the requisite fee
listed on the attached Fee Transmittal Sheet.

(d) D This Information Disclosure Statement is being submitted on or before the
payment of the issue fee; and:

L j Each item of information contained in this Information Disclosure
Statement was first cited in a communication from a foreign patent
office in a counterpart foreign application not more than three months
prior to the filing of this Information Disclosure Statement; or

O No item of information contained in this Information Disclosure
Statement was cited in a communication from a foreign patent office
in a counterpart foreign application, and, to the knowledge of the
undersigned after making reasonable inquiry, no item of information
contained in this Information Disclosure Statement was known to any
individual designated in § 1.56(c), more than three months prior to the
filing of this Information Disclosure Statement; and

O The Commissioner is hereby authorized to charge the requisite fee
listed on the attached Fee Transmittal Sheet.

[X] The Commissioner is hereby authorized to charge any additional fees which may be required
for this Information Disclosure Statement, or credit any overpayment to Deposit Account No.
23-0650.

Respectfully submitted,

THE WEBB LAW FIRM

Dated: October 18, 2007

700 Koppers Building
436 Seventh Avenue
Pittsburgh, Pennsylvania 15219
Telephone: 412-471-8815
Facsimile: 412-471-4094
E-mail: webblaw@webblaw.com

-^*^Thomas C. Wolskf
Reg. No. 55,739

KC1921.DOC

2